Cleared Traditional

K233666 - CorVista System with PH Add-On (FDA 510(k) Clearance)

Apr 2024
Decision
142d
Days
Class 2
Risk

K233666 is an FDA 510(k) clearance for the CorVista System with PH Add-On. This device is classified as a Pulmonary Hypertension Machine Learning-based Notification Software (Class II - Special Controls, product code SAT).

Submitted by Analytics For Life, Inc. (Toronto, CA). The FDA issued a Cleared decision on April 5, 2024, 142 days after receiving the submission on November 15, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2380. Pulmonary Hypertension Machine Learning-based Notification Software Employs Machine Learning Techniques To Suggest The Likelihood Of Pulmonary Hypertension For Further Referral Or Diagnostic Follow-up..

Submission Details

510(k) Number K233666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 2023
Decision Date April 05, 2024
Days to Decision 142 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code SAT - Pulmonary Hypertension Machine Learning-based Notification Software
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2380
Definition Pulmonary Hypertension Machine Learning-based Notification Software Employs Machine Learning Techniques To Suggest The Likelihood Of Pulmonary Hypertension For Further Referral Or Diagnostic Follow-up.